# Phase 6 Report — Analytics, Labs, and Model Integration

**Status: PASS**

## Delivered

- Added request-time analytics from database records, including the six simulator scenario outcomes labelled as demonstrations of system behaviour rather than clinical performance.
- Added scoped, audited, read-only simulated lab results.
- Added a fail-closed model registry and inference path. Only accepted artifacts in `models/active` with valid manifests, hashes, configuration, and files can load. No production model is deployed, so the user-facing no-model state is shown. NEWS2 remains the alert-driving score.
- Added a model prediction migration, API coverage, frontend coverage, and `docs/FUTURE_WORK.md`.

## Gate evidence

- Backend: `python -m pytest -q --basetemp ..\.tools\pytest-phase6` — **79 passed** against local PostgreSQL.
- Frontend unit tests: `npm test` — **18 passed**.
- Frontend production build and TypeScript check: `npm run build` — **passed**.
- Browser UI gate: Phase 4, Phase 5, and Phase 6 Playwright workflows — **passed**; Phase 6 produced nine screenshots across three viewports and axe-core reported zero serious or critical violations.
- Dynamic metric check changed underlying assessment data and confirmed the returned analytics changed accordingly.
- Model registry tests covered no artifact, unaccepted artifact, tampered artifact, and an isolated clearly marked accepted test fixture that produced a persisted prediction using the shared feature interface.
- Raw style scan and contrast checks — **passed**. UI evidence is recorded in `docs/UI_REVIEW.md`.

## Limitations and follow-up

- No trained model is deployed. The accepted test artifact is temporary test evidence, not a production model or clinical validation.
- Labs are synthetic, read-only, and excluded from NEWS2 scoring.
- Docker Compose startup and qualified clinician review remain **UNVERIFIED**.
- `npm install` reported nine audit findings (one moderate, six high, two critical); Phase 7 must review and remediate them without blind upgrades.
- Track B remains fixture-only pending the M0 data-governance decision and approved real-data training process.

## Next phase

Proceed to Phase 7 hardening: security review, dependency and secret scans, broader Playwright coverage, full UI audit, dead-code/dependency review, and complete test suites.
